Maxigesic® IV
Post-operative pain management
Approved/CommercialMarketed in >40 countries
Key Facts
Indication
Post-operative pain management
Phase
Approved/Commercial
Status
Marketed in >40 countries
Company
About AFT Pharmaceuticals
AFT Pharmaceuticals is a commercial-stage specialty pharma company with a significant presence in Australasia and growing operations in Asia. Its core business model involves licensing and marketing a wide range of pharmaceutical products, while its key growth driver is the global development and commercialization of its patented intravenous and oral analgesic, Maxigesic® (a fixed-dose combination of paracetamol/acetaminophen and ibuprofen). The company has successfully transitioned from a distributor to an innovator, with Maxigesic IV approved and launched in multiple countries and an extensive pipeline of line extensions.
View full company profile